A New Look at the Challenges in the Management of Hyponatremia

Hyponatremia is the most common electrolyte abnormality, yet mastering the intricacies of this important disorder can be challenging for trainees & seasoned faculty alike. Hyponatremia can have diverse causes and may require a combination of treatments. In this special Medicine Grand Rounds, jointly sponsored by the Divisions of Endocrinology & Nephrology, Visiting Professor Joseph Verbalis of Georgetown University enlightens us on the best practices for diagnosis and treatment of both acute and chronic hyponatremia.
Speaker:
Joseph G. Verbalis, MD, is professor of Medicine and Physiology, chief of the Division of Endocrinology and Metabolism, and Georgetown director of the Georgetown-Howard Universities Center for Clinical and Translational Science.
Dr. Verbalis graduated from Princeton University and received an MD from the University of Pittsburgh. He trained in internal medicine residency at the Hospital of the University of Pennsylvania and endocrinology fellowship at the University of Pittsburgh, where he remained on faculty from 1980-1995. After rising to the position of tenured Professor of Medicine, he then relocated to Georgetown University, where he is the Chief of the Division of Endocrinology and Metabolism. His NIH-funded research focuses on mechanisms underlying adaptation to hyponatremia, renal escape from vasopressin, osmotic regulation of hypothalamic gene expression, sex differences in physiology and pathophysiology, exercise-associated hyponatremia, hyponatremia-induced osteoporosis, and clinical use of vasopressin receptor antagonists. He has published over 300 journal articles, reviews, and book chapters related to these topics and is nationally and internationally known as a clinical and scientific expert in this area.
Note: Closed captions will be available within 48-72 hours after posting.
Program
Lekshmi Santhosh: Introduction
00:01:46-00:05:30 - Suneil Koliwad, MD (chief, Division of Endocrinology and Metabolism at UCSF Health)
00:05:34-01:02:53 - Joseph G. Verbalis, MD (professor of Medicine and Physiology, chief of the Division of Endocrinology and Metabolism, Georgetown director of the Georgetown-Howard Universities Center for Clinical and Translational Science)
01:02:55-01:09:31 - Q&A
See previous Medical Grand Rounds:
• April 13: What’s New in 2023 in the Management of Heart Failure?
• What’s New in 2023 in ...
• April 6: A Conversation with FDA Commissioner Robert Califf
• A Conversation with FD...
• March 30: Progress in Obstructive Lung Disease: Bedside to Bench and Back
• Progress in Obstructiv...
• March 23: Clinical Problem Solving
• Clinical Problem Solving
See all UCSF Covid-19 grand rounds, which have been viewed over 3M times, at • UCSF Department of Med... .

[@integrityshines561]

Excellent lecture. Can sglt 2 inhibitors cause hyponatremia?